Clarithromycin or levofloxacin in the sequential therapy for H. pylori eradication?
A
A
Zullo
C
C
Hassan
C
C
D'Ercole
V
V
De Francesco
D
D
Vaira
D000293:Adolescent; D000328:Adult; D000368:Aged; D017291:Clarithromycin / Q000191:economics / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D016481:Helicobacter Infections / Q000188:drug therapy*; D016480:Helicobacter pylori / Q000187:drug effects*; D006801:Humans; D064704:Levofloxacin; D008297:Male; D008795:Metronidazole / Q000592:standards; D008875:Middle Aged; D015242:Ofloxacin / Q000191:economics / Q000592:standards / Q000627:therapeutic use*; D014011:Tinidazole / Q000592:standards* / Q000627:therapeutic use; D055815:Young Adult
D014011:Tinidazole; D008795:Metronidazole; D064704:Levofloxacin; D015242:Ofloxacin; D017291:Clarithromycin